| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Restricted Stock Units | Award | $0 | +2,044 | $0.000000 | 2,044 | 28 May 2024 | Common Stock | 2,044 | Direct | F1 | ||
| transaction | FLS | Restricted Stock Units | Award | $0 | +3,781 | +185% | $0.000000 | 5,825 | 28 May 2024 | Common Stock | 3,781 | Direct | F2 | |
| transaction | FLS | Performance Rights | Award | $0 | +3,781 | $0.000000 | 3,781 | 28 May 2024 | Common Stock | 3,781 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. |
| F2 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025. |
| F3 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. |